BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

513 related articles for article (PubMed ID: 21397996)

  • 1. Benzophenone-based derivatives: a novel series of potent and selective dual inhibitors of acetylcholinesterase and acetylcholinesterase-induced beta-amyloid aggregation.
    Belluti F; Bartolini M; Bottegoni G; Bisi A; Cavalli A; Andrisano V; Rampa A
    Eur J Med Chem; 2011 May; 46(5):1682-93. PubMed ID: 21397996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, in vitro assay, and molecular modeling of new piperidine derivatives having dual inhibitory potency against acetylcholinesterase and Abeta1-42 aggregation for Alzheimer's disease therapeutics.
    Kwon YE; Park JY; No KT; Shin JH; Lee SK; Eun JS; Yang JH; Shin TY; Kim DK; Chae BS; Leem JY; Kim KH
    Bioorg Med Chem; 2007 Oct; 15(20):6596-607. PubMed ID: 17681794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Syntheses and characterization of novel oxoisoaporphine derivatives as dual inhibitors for cholinesterases and amyloid beta aggregation.
    Li YP; Ning FX; Yang MB; Li YC; Nie MH; Ou TM; Tan JH; Huang SL; Li D; Gu LQ; Huang ZS
    Eur J Med Chem; 2011 May; 46(5):1572-81. PubMed ID: 21367493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis and evaluation of novel tacrine-multialkoxybenzene hybrids as dual inhibitors for cholinesterases and amyloid beta aggregation.
    Luo W; Li YP; He Y; Huang SL; Tan JH; Ou TM; Li D; Gu LQ; Huang ZS
    Bioorg Med Chem; 2011 Jan; 19(2):763-70. PubMed ID: 21211982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and evaluation of heterobivalent tacrine derivatives as potential multi-functional anti-Alzheimer agents.
    Luo W; Li YP; He Y; Huang SL; Li D; Gu LQ; Huang ZS
    Eur J Med Chem; 2011 Jun; 46(6):2609-16. PubMed ID: 21497959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New potent human acetylcholinesterase inhibitors in the tetracyclic triterpene series with inhibitory potency on amyloid β aggregation.
    Rouleau J; Iorga BI; Guillou C
    Eur J Med Chem; 2011 Jun; 46(6):2193-205. PubMed ID: 21435752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis and biological evaluation of benzo[e][1,2,4]triazin-7(1H)-one and [1,2,4]-triazino[5,6,1-jk]carbazol-6-one derivatives as dual inhibitors of beta-amyloid aggregation and acetyl/butyryl cholinesterase.
    Catto M; Berezin AA; Lo Re D; Loizou G; Demetriades M; De Stradis A; Campagna F; Koutentis PA; Carotti A
    Eur J Med Chem; 2012 Dec; 58():84-97. PubMed ID: 23108363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, biological evaluation and molecular modeling of novel triazole-containing berberine derivatives as acetylcholinesterase and β-amyloid aggregation inhibitors.
    Shi A; Huang L; Lu C; He F; Li X
    Bioorg Med Chem; 2011 Apr; 19(7):2298-305. PubMed ID: 21397508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholinesterase inhibitors: xanthostigmine derivatives blocking the acetylcholinesterase-induced beta-amyloid aggregation.
    Belluti F; Rampa A; Piazzi L; Bisi A; Gobbi S; Bartolini M; Andrisano V; Cavalli A; Recanatini M; Valenti P
    J Med Chem; 2005 Jun; 48(13):4444-56. PubMed ID: 15974596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis and evaluation of isaindigotone derivatives as dual inhibitors for acetylcholinesterase and amyloid beta aggregation.
    Yan JW; Li YP; Ye WJ; Chen SB; Hou JQ; Tan JH; Ou TM; Li D; Gu LQ; Huang ZS
    Bioorg Med Chem; 2012 Apr; 20(8):2527-34. PubMed ID: 22444876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis and evaluation of flavonoid derivatives as potential multifunctional acetylcholinesterase inhibitors against Alzheimer's disease.
    Li RS; Wang XB; Hu XJ; Kong LY
    Bioorg Med Chem Lett; 2013 May; 23(9):2636-41. PubMed ID: 23511019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
    Brunhofer G; Fallarero A; Karlsson D; Batista-Gonzalez A; Shinde P; Gopi Mohan C; Vuorela P
    Bioorg Med Chem; 2012 Nov; 20(22):6669-79. PubMed ID: 23062825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis, and evaluation of benzophenone derivatives as novel acetylcholinesterase inhibitors.
    Belluti F; Piazzi L; Bisi A; Gobbi S; Bartolini M; Cavalli A; Valenti P; Rampa A
    Eur J Med Chem; 2009 Mar; 44(3):1341-8. PubMed ID: 18396354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis and biological activity of novel donepezil derivatives bearing N-benzyl pyridinium moiety as potent and dual binding site acetylcholinesterase inhibitors.
    Lan JS; Zhang T; Liu Y; Yang J; Xie SS; Liu J; Miao ZY; Ding Y
    Eur J Med Chem; 2017 Jun; 133():184-196. PubMed ID: 28388521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis and evaluation of novel 2-(aminoalkyl)-isoindoline-1,3-dione derivatives as dual-binding site acetylcholinesterase inhibitors.
    Ignasik M; Bajda M; Guzior N; Prinz M; Holzgrabe U; Malawska B
    Arch Pharm (Weinheim); 2012 Jul; 345(7):509-16. PubMed ID: 22467516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting Alzheimer's disease: Novel indanone hybrids bearing a pharmacophoric fragment of AP2238.
    Rizzo S; Bartolini M; Ceccarini L; Piazzi L; Gobbi S; Cavalli A; Recanatini M; Andrisano V; Rampa A
    Bioorg Med Chem; 2010 Mar; 18(5):1749-60. PubMed ID: 20171894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis, and biological evaluation of conformationally restricted rivastigmine analogues.
    Bolognesi ML; Bartolini M; Cavalli A; Andrisano V; Rosini M; Minarini A; Melchiorre C
    J Med Chem; 2004 Nov; 47(24):5945-52. PubMed ID: 15537349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and evaluation of 7,8-dehydrorutaecarpine derivatives as potential multifunctional agents for the treatment of Alzheimer's disease.
    He Y; Yao PF; Chen SB; Huang ZH; Huang SL; Tan JH; Li D; Gu LQ; Huang ZS
    Eur J Med Chem; 2013 May; 63():299-312. PubMed ID: 23501115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of multifunctional, heterodimeric isoindoline-1,3-dione derivatives as cholinesterase and β-amyloid aggregation inhibitors with neuroprotective properties.
    Guzior N; Bajda M; Skrok M; Kurpiewska K; Lewiński K; Brus B; Pišlar A; Kos J; Gobec S; Malawska B
    Eur J Med Chem; 2015 Mar; 92():738-49. PubMed ID: 25621991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, biological evaluation, and molecular modeling of donepezil and N-[(5-(benzyloxy)-1-methyl-1H-indol-2-yl)methyl]-N-methylprop-2-yn-1-amine hybrids as new multipotent cholinesterase/monoamine oxidase inhibitors for the treatment of Alzheimer's disease.
    Bolea I; Juárez-Jiménez J; de Los Ríos C; Chioua M; Pouplana R; Luque FJ; Unzeta M; Marco-Contelles J; Samadi A
    J Med Chem; 2011 Dec; 54(24):8251-70. PubMed ID: 22023459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.